Cargando…
Suspected acute exacerbation of idiopathic pulmonary fibrosis as an outcome measure in clinical trials
BACKGROUND: Acute exacerbation of idiopathic pulmonary fibrosis has become an important outcome measure in clinical trials. This study aimed to explore the concept of suspected acute exacerbation as an outcome measure. METHODS: Three investigators retrospectively reviewed subjects enrolled in the Si...
Autores principales: | Collard, Harold R, Yow, Eric, Richeldi, Luca, Anstrom, Kevin J, Glazer, Craig |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3729659/ https://www.ncbi.nlm.nih.gov/pubmed/23848435 http://dx.doi.org/10.1186/1465-9921-14-73 |
Ejemplares similares
-
Acute Exacerbation of Idiopathic Pulmonary Fibrosis
por: Lee, Joyce S., et al.
Publicado: (2013) -
Acute Exacerbation of Idiopathic Pulmonary Fibrosis
por: Lee, Joyce S., et al.
Publicado: (2018) -
Differing severities of acute exacerbations of idiopathic pulmonary fibrosis (IPF): insights from the INPULSIS® trials
por: Kreuter, Michael, et al.
Publicado: (2019) -
3541 The association of corticosteroid use with inpatient mortality in acute exacerbation of idiopathic pulmonary fibrosis
por: Farrand, Erica, et al.
Publicado: (2019) -
COVID-19 Vaccine in Patients with Exacerbation of Idiopathic Pulmonary Fibrosis
por: Sgalla, Giacomo, et al.
Publicado: (2022)